{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["22(5)"],"submitter":["Ryan MJ"],"funding":["Government of Western Australia","Spinnaker Foundation","Fiona Stanley Hospital","Fiona Wood Foundation","National Institute for Health Research (NIHR)","Australian Government","Department of Jobs, Tourism, Science and Innovation","Medical Research Future Fund","Australian Research Council"],"pubmed_abstract":["Dysregulated lipid metabolism underpins many chronic diseases including cardiometabolic diseases. Mass spectrometry-based lipidomics is an important tool for understanding mechanisms of lipid dysfunction and is widely applied in epidemiology and clinical studies. With ever-increasing sample numbers, single batch acquisition is often unfeasible, requiring advanced methods that are accurate and robust to batch-to-batch and interday analytical variation. Herein, an optimized comprehensive targeted workflow for plasma and serum lipid quantification is presented, combining stable isotope internal standard dilution, automated sample preparation, and ultrahigh performance liquid chromatography-tandem mass spectrometry with rapid polarity switching to target 1163 lipid species spanning 20 subclass"],"journal":["Journal of proteome research"],"pagination":["1419-1433"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10167688"],"repository":["biostudies-literature"],"pubmed_title":["Comprehensive Lipidomic Workflow for Multicohort Population Phenotyping Using Stable Isotope Dilution Targeted Liquid Chromatography-Mass Spectrometry."],"pmcid":["PMC10167688"],"pubmed_authors":["Maker GL","Fear MW","Lawler NG","Wood FM","Holmes E","Whiley L","Raby E","Ryan MJ","Grant-St James A","Nicholson JK","Gray N","Wist J"],"additional_accession":[]},"is_claimable":false,"name":"Comprehensive Lipidomic Workflow for Multicohort Population Phenotyping Using Stable Isotope Dilution Targeted Liquid Chromatography-Mass Spectrometry.","description":"Dysregulated lipid metabolism underpins many chronic diseases including cardiometabolic diseases. Mass spectrometry-based lipidomics is an important tool for understanding mechanisms of lipid dysfunction and is widely applied in epidemiology and clinical studies. With ever-increasing sample numbers, single batch acquisition is often unfeasible, requiring advanced methods that are accurate and robust to batch-to-batch and interday analytical variation. Herein, an optimized comprehensive targeted workflow for plasma and serum lipid quantification is presented, combining stable isotope internal standard dilution, automated sample preparation, and ultrahigh performance liquid chromatography-tandem mass spectrometry with rapid polarity switching to target 1163 lipid species spanning 20 subclass","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 May","modification":"2025-04-05T09:11:58.624Z","creation":"2025-04-05T09:11:58.624Z"},"accession":"S-EPMC10167688","cross_references":{"pubmed":["36828482"],"doi":["10.1021/acs.jproteome.2c00682"]}}